Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1928-1933
doi: 10.1161/hq1201.100227
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Kovanen, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Kovanen, P. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Smooth muscle proliferation and differentiation
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1928.)
© 2001 American Heart Association, Inc.


Vascular Biology

Mast Cell Chymase Inhibits Smooth Muscle Cell Growth and Collagen Expression In Vitro

Transforming Growth Factor-ß1-Dependent and -Independent Effects

Yenfeng Wang; Naotaka Shiota; Markus J. Leskinen; Ken A. Lindstedt; Petri T. Kovanen

From the Wihuri Research Institute, Helsinki, Finland.

Reprint requests to Petri T. Kovanen, MD, PhD, Wihuri Research Institute, Kalliolinnantie 4, FIN-00140 Helsinki, Finland. E-mail petri.kovanen{at}wri.fi

In the vulnerable areas of fibrous caps of advanced atherosclerotic lesions, chymase-containing mast cells are present. In such areas, the numbers of smooth muscle cells (SMCs) and the content of collagen are reduced. In this in vitro study, we found that the addition of chymase, isolated and purified from rat serosal mast cells, to cultured rat aortic SMCs of the synthetic phenotype (s-SMCs) inhibited their proliferation by blocking the G0/G1->S transition in the cell cycle. Rat chymase and recombinant human chymase inhibited the expression of collagen type I and type III mRNA in s-SMCs and in human coronary arterial SMCs. The growth-inhibitory effect of chymase was partially reversed by addition to the culture medium of an antibody capable of neutralizing the activity of transforming growth factor-ß1 (TGF-ß1). Immunocytochemistry showed that the s-SMCs expressed and synthesized extracellular matrix-associated TGF-ß1. On exposure to mast cell chymase, the extracellular matrix-associated latent TGF-ß1 was released and activated, as demonstrated by immunoblotting and by an ELISA with TGF-ß1 type II receptor for capture. When added to s-SMCs, such chymase-released TGF-ß1 was capable of inhibiting their growth. In contrast, the inhibitory effect of chymase on collagen synthesis by s-SMCs did not depend on TGF-ß1. Taken together, the findings support the hypothesis that chymase released from activated mast cells in atherosclerotic plaques contributes to cap remodeling.


Key Words: atherosclerosis • smooth muscle cells • transforming growth factor-ß • collagen • chymase




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Joseph, R. H. Kennedy, S. Devi, J. Wang, L. Joseph, and M. Hauer-Jensen
Protective role of mast cells in homocysteine-induced cardiac remodeling
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2541 - H2545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. G. Phillips, L. Long, M. R. Wilkins, and N. W. Morrell
cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L103 - L115.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. A. Lindstedt, M. J. Leskinen, and P. T. Kovanen
Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture
Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. A Doggrell and J. C Wanstall
Vascular chymase: pathophysiological role and therapeutic potential of inhibition
Cardiovasc Res, March 1, 2004; 61(4): 653 - 662.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Cullen, R. Baetta, S. Bellosta, F. Bernini, G. Chinetti, A. Cignarella, A. von Eckardstein, A. Exley, M. Goddard, M. Hofker, et al.
Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist?
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 535 - 542.
[Abstract] [Full Text] [PDF]